Back to Journals » Drug Design, Development and Therapy » Volume 11

Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models

Total article views   HTML views PDF downloads Totals
23,917 Dovepress* 16,335+ 1,460 17,795
PubMed Central* 7,582 539 8,121
Totals 23,917 1,999 25,916
*Since 11 April 2017
Total mentioned Facebook Delicious Reddit Twitter Others
10 1 0 0 4 5

View citations on PubMed Central and Google Scholar